All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

GLP-1 Prescriptions Surge Sevenfold Among Women With PCOS: What to Know About Off-Label Use

GLP-1 drug prescriptions (like Ozempic, Wegovy, Zepbound, Mounjaro) among women with PCOS have surged over sevenfold since 2021, despite these medications not being FDA-approved specifically for PCOS treatment. The article explains how GLP-1 receptor agonists work for people with PCOS who struggle with insulin resistance, covering mechanisms of action, benefits, risks, and practical considerations for those using these medications off-label for PCOS management.

Angela Grassi2d ago11 min readenInsight
Read on pcosnutrition.com

Key quotes

New research shows U.S. prescriptions for GLP-1 drugs among women with PCOS have surged more than sevenfold since 2021, despite these drugs not being approved as a treatment for PCOS.
How do Ozempic and other Glucagon-like peptide 1 (GLP-1) receptor agonists (GLP-1s) like Wegovy, Zepbound, Mounjaro, work for people with PCOS who struggle with insulin resistance?
What concerns or risks are there for folks with PCOS who are using these medications?

From the article

Wondering how GLP-1 drugs like Wegovy, Zepbound and Munjaro, work for people with PCOS? Here’s what you need to know.
Continue reading on pcosnutrition.com

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.